169 filings
Page 2 of 9
8-K
36w12mzoytm
13 Jul 22
Other Events
4:14pm
8-K
eq489
5 Jul 22
Precigen Enters into Agreement to Divest Non-Healthcare Subsidiary Trans Ova Genetics
8:25am
8-K
0hiu0mgykls59q7h
14 Jun 22
Submission of Matters to a Vote of Security Holders
4:21pm
8-K
8freu
9 May 22
Precigen Reports First Quarter 2022 Financial Results and Business Updates
4:14pm
8-K
9yyn1f15ctnskbr7
1 Mar 22
Precigen Reports Fourth Quarter and Full Year 2021 Financial Results
8:14am
8-K
j4a1m4c
4 Nov 21
Precigen Achieves Significant Clinical Progress for UltraCAR-TĀ® and AdenoVerseā¢ Therapies
9:29am
8-K
krh8r15gp20mnz98l
12 Oct 21
Precigen Appoints Harry Thomasian Jr. as Chief Financial Officer
8:10am
8-K
3lrqk 17yh5nrxgl
9 Aug 21
Precigen Reports Second Quarter and First Half 2021 Financial Results
4:03pm
8-K
qsdrugdl
15 Jun 21
Submission of Matters to a Vote of Security Holders
4:21pm
8-K
jytsrom40o58j 3ccu
28 May 21
Departure of Directors or Certain Officers
6:12am
8-K
qj27uquep ec264jhmc9
10 May 21
Precigen Reports First Quarter 2021 Financial Results
4:44pm
8-K
hvpibjy0
30 Mar 21
Precigen Announces Departure of Chief Financial Officer
12:00am
8-K
bm75r9izux9 zb
1 Mar 21
Precigen Reports Fourth Quarter and Full Year 2020 Financial Results
4:18pm
8-K
h3t1d 60vv476wqlm
26 Jan 21
Entry into a Material Definitive Agreement
4:13pm
8-K
lawtgb9tenxapi6wv3
13 Jan 21
Regulation FD Disclosure
4:32pm
8-K
cj04khe3xl5
2 Dec 20
Unregistered Sales of Equity Securities
5:00pm
8-K
4qcis6nqbo77 cewgbye
9 Nov 20
Precigen Reports Third Quarter 2020 and Year-to-Date Financial Results
8:14am
8-K
wyxmdqx51jb
9 Oct 20
Precigen Announces Merck KGaA, Darmstadt, Germany Increases Ownership Position Through Exercise of Convertible Note
7:43am
8-K
miobri9z 21xiozh5rl
25 Sep 20
Other Events
4:17pm
8-K
rnzc6bpw
25 Sep 20
Unregistered Sales of Equity Securities
4:15pm